PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Depression and anxiety not linked to delayed resolution of abnormal mammograms, Pap tests

2011-11-23
(Press-News.org) Boston – In what is believed to be the first study of its kind to examine the relationship between pre-existing depression (with and without anxiety) and the amount of time to diagnostically resolve an abnormal mammogram and/or Pap test, researchers from Boston University School of Medicine (BUSM) have found suffering from depression was not associated with a prolonged time to diagnostic resolution in a vulnerable population of urban women. These findings currently appear in the Journal of General Internal Medicine.

Delays in care after abnormal cancer screenings contribute to disparities in cancer out- comes. Women with psychiatric disorders are less likely to receive cancer screening and may also have delays in diagnostic resolution after an abnormal screening test. Vulnerable populations of women, as defined by low income or with racial/ethnic minority status, are less likely to receive standard preventive health care, which contributes to worse breast and cervical cancer outcomes. Depression is prevalent in these populations, and may lead to worse healthcare outcomes.

The BUSM researchers conducted a retrospective chart review of electronic medical records to identify women who had a diagnosis of depression or anxiety in the year prior to the abnormal mammogram or Pap test. They used time-to-event analysis to analyze the outcome of time to resolution after abnormal cancer screening.

Of the women with abnormal mammogram and Pap tests, the researchers found 19 percent and 16 percent, respectively, suffered with depression. The median time to resolution was 27 days for women with abnormal mammograms and 85 days for women with abnormal Pap tests. However, there was no difference in time to diagnostic resolution between depressed and not-depressed women for those with abnormal mammograms or Pap tests.

The researchers believe that documented mood disorders are not an additional barrier to resolution after an abnormal cancer screening test in this vulnerable population of women who already had barriers to receiving healthcare. "Although we found delays in diagnostic resolution after abnormal cancer screening, women with a depression diagnosis did not have increased delays compared to those who were not depressed," explained lead author Andrea Kronman, MD, MSc, assistant professor of medicine at BUSM.

"Pre-screening the electronic medical records of women for mood disorders may not be the most reliable approach to identify a group of patients at higher risk of delayed diagnostic resolution of abnormal cancer screening tests in a vulnerable population," added Kronman.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Olinsky Law Group Donates $100,000 to Burton Blatt Institute at Syracuse University

2011-11-23
In support of the Burton Blatt Institute (BBI) at Syracuse University, Howard D. Olinsky, L'85, a disability law attorney representing clients across the country, has announced a commitment of $100,000 to BBI, one of the institute's most generous private donations. "This fantastic gift will help ensure that BBI builds the next generation of young leaders by supporting fellowships for law students to positively impact people with disabilities," said University Professor Peter Blanck, BBI chairman. "Howard's commitment is a perfect example of an investment ...

Olympic Villages: Catalyst for urban renewal, or post-Games hangover?

2011-11-23
The Olympic Games are big business and generate substantial amounts of revenue for the International Olympic Committee (IOC) through lucrative television contracts and corporate sponsorship. The Games are now also widely perceived as important promotional opportunities for cities seeking to reinforce their claims as 'world class' destinations for tourists and capital in the global economy. Related to these latter goals, beginning with the 1992 Barcelona Olympics, the Games have also been envisioned by civic elites as opportunities to develop under-utilized land through ...

Arginine restores T-cell ability to target cancer

2011-11-23
In many cases, tumors suppress a patient's immune system in a way that keeps the cancer safe from immune system attack. This is particularly true for patients with glioblastoma, a primary brain tumor that carries a prognosis of only 12-15 months survival after diagnosis. A study at the University of Colorado Cancer Center, recently published as a featured article in the journal Clinical Cancer Research, shows that treatment with the over-the-counter amino acid arginine may reactivate cancer-fighting T-cells in patients with glioblastoma, thus potentially allowing the ...

Schachter Harris Wins Garlock Sealing Technologies Case

2011-11-23
We represented Garlock Sealing Technologies, LLC in an appeal of a judgment against Garlock entered by the US District Court in Louisville, Kentucky. The United States Court of Appeals for the Sixth Circuit reversed the judgment and effectively rendered judgment against the plaintiff in Garlock's favor. The plaintiff, Olwen Moeller, individually and as executrix for the estate of Robert L. Moeller, sued Garlock alleging Mr. Moeller's work as a pipefitter with asbestos-containing gaskets made by Garlock were a substantial cause of his mesothelioma. Plaintiff supported ...

Blocked holes can enhance rather than stop light going through

Blocked holes can enhance rather than stop light going through
2011-11-23
Conventional wisdom would say that blocking a hole would prevent light from going through it, but Princeton University engineers have discovered the opposite to be true. A research team has found that placing a metal cap over a small hole in a metal film does not stop the light at all, but rather enhances its transmission. In an example of the extraordinary twists of physics that can occur at very small scales, electrical engineer Stephen Chou and colleagues made an array of tiny holes in a thin metal film, then blocked each hole with an opaque metal cap. When they shined ...

Martin Banks Adds New Social Security Disability Attorney

Martin Banks Adds New Social Security Disability Attorney
2011-11-23
The law firm of Martin Banks has expanded its Social Security Disability and Long-Term Disability practice with the addition of Associate, Maria E. Harris. Ms. Harris focuses her practice exclusively on Social Security and Long-Term Disability law. Prior to joining the firm, Ms. Harris practiced at an international defense firm litigating insurance matters in the areas of life, health, disability and ERISA claims. She has also previously served as a law clerk in the Family Division of the Superior Court of New Jersey. In 2007, Ms. Harris earned her law degree from Widener ...

Moffitt Cancer Center researchers find men less willing to be screened for cancer

2011-11-23
TAMPA, Fla. -- Although men have higher cancer mortality rates than women, they are less willing to be screened for cancer, according to a study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Sanoa Consulting LLC, Muscle Shoals, Ala., and the New York University College of Dentistry. The study, which was funded by the National Institute of Dental and Craniofacial Research/National Institutes of Health, was conducted in New York City, Baltimore, Maryland and San Juan, Puerto Rico, through a random-dial telephone survey of 1,148 adult ...

L-arginine: Supplement tested on fit, athletic men shows no advantage

2011-11-23
One of the most recent, popular supplements for athletes looking to boost performance comes in the form of a naturally-occurring amino acid called L-arginine. The reason for its popularity is twofold says Scott Forbes, a doctoral student in exercise physiology. "First, L-arginine is a precursor for nitric oxide that is known to improve blood flow, which in turn may aid the delivery of important nutrients to working muscles and assist with metabolic waste product removal. Secondly, L-arginine has been shown to increase growth hormone levels in the blood." The benefits ...

Use of retail medical clinics rises 10-fold over 2-year period, study finds

2011-11-23
Use of retail medical clinics located in pharmacies and other retail settings increased 10-fold between 2007 and 2009, according to a new RAND Corporation study. The determining factors in choosing a retail medical clinic over a physician's office were found to be age, health status, income and proximity to the clinic. No link between availability of a primary care physician and retail clinic use was found. The study was published in the American Journal of Managed Care. The RAND team used data from a commercially-insured population of 13.3 million to describe ...

Nanowrinkles, nanofolds yield strange hidden channels

Nanowrinkles, nanofolds yield strange hidden channels
2011-11-23
PROVIDENCE, R.I. -- Wrinkles and folds are ubiquitous. They occur in furrowed brows, planetary topology, the surface of the human brain, even the bottom of a gecko's foot. In many cases, they are nature's ingenious way of packing more surface area into a limited space. Scientists, mimicking nature, have long sought to manipulate surfaces to create wrinkles and folds to make smaller, more flexible electronic devices, fluid-carrying nanochannels or even printable cell phones and computers. But to attain those technology-bending feats, scientists must fully understand the ...

LAST 30 PRESS RELEASES:

Scientists uncover key to decoupling economic growth from pollution in developing countries

Frailty fuels gut imbalance and post-surgery gastrointestinal risks

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

[Press-News.org] Depression and anxiety not linked to delayed resolution of abnormal mammograms, Pap tests